Novartis Pharmaceuticals Corporation v. Accord Healthcare, Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Dr.…

N OTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
January 4, 2022
ERRATA
______________________
Appeal No. 21-1070
NOVARTIS PHARMACEUTICALS CORPORATION,
Plaintiff-Appellee
v.
ACCORD HEALTHCARE, INC., AUROBINDO
PHARMA LTD., AUROBINDO PHARMA USA, INC.,
DR. REDDY'S LABORATORIES, INC., DR. REDDY'S
LABORATORIES, LTD., EMCURE
PHARMACEUTICALS LTD., HERITAGE
PHARMACEUTICALS INC., GLENMARK
PHARMACEUTICALS INC., USA, GLENMARK
PHARMACEUTICALS LIMITED, HETERO USA,
INC., HETERO LABS LIMITED UNIT-V, HETERO
LABS LIMITED, MYLAN PHARMACEUTICALS,
INC., PRINSTON PHARMACEUTICAL INC.,
STRIDES GLOBAL PHARMA PRIVATE LIMITED,
STRIDES PHARMA, INC., TORRENT PHARMA
INC., TORRENT PHARMACEUTICALS LTD.,
ZYDUS PHARMACEUTICALS (USA) INC., CADILA
HEALTHCARE LTD., APOTEX INC., APOTEX
CORP., SUN PHARMACEUTICAL INDUSTRIES,
LTD., SUN PHARMACEUTICAL INDUSTRIES INC.,
Case: 21-1070 Document: 43 Page: 1 Filed: 01/04/2022

-- 1 of 2 --

NOVARTIS PHARMACEUTICALS v. ACCORD HEALTHCARE INC. 2
SUN PHARMA GLOBAL FZE,
Defendants
HEC PHARM CO., LTD., HEC PHARM USA INC.,
Defendants-Appellants
Decided: January 3, 2022
Precedential opinion
______________________
Please make the following change:
Page 2, line 7 (majority opinion): the issuance date of
“January 3, 2021” is changed to “January 3, 2022”.
Case: 21-1070 Document: 43 Page: 2 Filed: 01/04/2022

-- 2 of 2 --